Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Lungs Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
Authors: S Jana 
Published: January 2024

The aim of this experiment was to evaluate the antioxidant and anti-inflammatory potential of the Biofield Energy Treated Proprietary Test Formulation and Biofield Energy Treatment per se to the animals on Cecal Slurry, LPS and E. coli-induced systemic inflammatory response syndrome (SIRS) model in Sprague Dawley rats using lungs antioxidants and cytokines. In this experiment, various antioxidants like myeloperoxidase (MPO), superoxide dismutase (SOD), lipid peroxidation (LPO) and proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), macrophage inflammatory protein-2 (MIP-2) were analysed using ELISA assay in lungs. A test formulation was formulated including minerals (magnesium, zinc, calcium, selenium, and iron), vitamins (ascorbic acid, pyridoxine HCl, vitamin E, cyanocobalamin, and cholecalciferol), Panax ginseng extract, β-carotene, and cannabidiol isolate. The constituents of the test formulation were divided into two parts; one section was defined as the untreated test formulation, while the other portion of the test formulation and three group of animals received Biofield Energy Healing Treatment remotely for about 3 minutes by a renowned Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. The level of MPO was reduced by 45.77%, 53.36%, 47.80%, 53.89%, and 57.72% in the G5 (Cecal Slurry, LPS and E. coli along with the Biofield Energy Treated test formulation); G6 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se to animals from day -15); G7 (Cecal Slurry, LPS and E. coli along with the Biofield Energy Treated test formulation from day -15); G8 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se plus the Biofield Energy Treated test formulation from day -15), and G9 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se animals plus the untreated test formulation) groups, respectively as compared to the disease control (G2) group. Additionally, the level of SOD was increased by 7% in the G9 group as compared to the untreated test formulation (G4) group. The level of lipid peroxidation (LPO) end product in terms of malondialdehyde (MDA) was significantly reduced by 15.46% (p≤0.05), 14.53% (p≤0.05), and 11.88% in the G5, G6, G7, and G8 groups, respectively as compared to the G4 group. The level of TNF-α was decreased by 15.05%, 42.48% (p≤0.001), 48.73% (p≤0.001), and 42.85% (p≤0.001) in the G5, G6, G7, and G8 groups, respectively as compared to the G2 group. Moreover, the level of IL-6 was decreased by 29.44% (p≤0.001), 19%, 39.56% (p≤0.001), and 40.79% (p≤0.001) in the G5, G6, G7, and G8 groups, respectively as compared to the G2 group. Additionally, the level of MIP-2 was reduced by 10.99%, 14.37%, 40.16%, 16.75%, and 18.41% in the G5, G6, G7, G8, and G9 groups, respectively as compared to the G4 group. Overall, the data suggested the antioxidant and anti-inflammatory potentials of the Biofield Energy. Treated test formulation and Biofield Energy Treatment per se along with preventive measure on the animal with respect to various inflammatory conditions that might be beneficial various types of systemic inflammatory disorders specially sepsis, trauma, septic shock or any types of injuries. Therefore, the results showed the significant slowdown the inflammation-related disease progression and its complications/symptoms in the preventive Biofield Energy Treatment group per se and/or Biofield Energy Treated Test formulation groups (viz. G6, G7, G8, and G9) comparatively with the disease control group.